Venous thromboembolism (VTE) can exist as deep vein thrombosis or pulmonary embolism. VTE has an incidence of about 1.5 in 1000 people per year and a lifetime prevalence of more than 5%. The diagnosis of VTE requires an urgent assessment. Generally, anticoagulation is needed to diminish the risk of fatal pulmonary embolism and morbidity from recurrent VTE, post-thrombotic syndrome, and pulmonary hypertension. 1 In this regard, Sanofi in collaboration with ISCCM and Docplexus have organized an interactive Webinar and multi-panel discussion on 23 rd July 2020 from 03:00 to 05:00 PM. In this webinar, the expert panel ( Dr. Abhay A. Bhave , Prof.
Roopen Arya, Prof. Juan Arcelus, Dr. Ashit V. Hegde, Dr. Raghuram Sekhar, and Dr. Abdul Samad Ansari ) will share their experiences and discuss “VTE management in medical and surgical patients”. Reference: Stevens H et al., Australian…
